<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSM1049430"><item key="VARIATION">RKIP-transgenic (expressing RKIP under control of the myocardium-specific alpha-MHC promoter)</item></item></item><item><item key="GSM1049430"><item key="VARIATION">RKIP-transgenic (expressing RKIP under control of the myocardium-specific alpha-MHC promoter)</item></item></item><item><item key="GSM1049432"><item key="VARIATION">GRK-Inh-transgenic (myocardium-specific expression of a GRK-specific peptide inhibitor)</item></item></item><item><item key="GSM1049432"><item key="VARIATION">GRK-Inh-transgenic (myocardium-specific expression of a GRK-specific peptide inhibitor)</item></item></item><item><item key="GSM1049434"><item key="VARIATION">wild type (control)</item></item></item><item><item key="GSM1049434"><item key="VARIATION">wild type (control)</item></item></item></item><item key="id">7097</item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">The Raf kinase inhibitor protein (RKIP) is a dual inhibitor of the Raf kinase and the G-protein-coupled receptor kinase 2 (GRK2). GRK2 is...</item><item key="geo_gse_id">E-GEOD-42753</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>heart</item><item>myocardium</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">microarray-gene-expression-profiling-of-transgenic</item><item key="geo_id_plat">E-GEOD-42753_A-AFFY-45</item><item key="name">Microarray gene expression profiling of transgenic mice with myocardium-specific expression of RKIP or a GRK-specific peptide inhibitor</item><item key="created">Nov.12, 2014</item><item key="summary">The Raf kinase inhibitor protein (RKIP) is a dual inhibitor of the Raf kinase and the G-protein-coupled receptor kinase 2 (GRK2). GRK2 is an indispensable kinase, which exerts a major role in the pathogenesis of heart failure, and inhibition of GRK2 is cardioprotective in experimental models of heart failure. To investigate the cardiac function of RKIP as GRK2 inhibitor, we generated transgenic mice with myocardium-specific expression of RKIP under control of the alpha-MHC promoter. For comparison, mice with myocardium-specific expression of a GRK-specific peptide inhibitor (GRK-Inh) were also generated. Two different transgenic mouse models were established. Transgenic RKIP mice and transgenic GRK-Inh mice were born at Mendelian frequencey and grew to adulthood normally. Microarray gene expression profiling was performed with heart tissue isolated from three study groups: (i) RKIP-transgenic mice, (ii) GRK-Inh-transgenic mice, and (iii) B6 control mice.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-42753</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-42753/samples/</item></data></biogps>
